Skip to content
Wenlo
Sign in
← Markets

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares

144REGNFiled Nov 4, 2026, 4:45 PM ET

AI-generated summary

Officer Jason Pitofsky filed to propose the sale of 180 shares of Common Stock with an aggregate market value of $175,204.80 through J.P. Morgan Securities LLC. The shares are to be sold by Stephanie Pitofsky, having been inherited on August 13, 2024.

Key facts

Seller
Jason Pitofsky
Relationship
Officer
Shares to sell
180
Market value
$175,204.80
Approximate sale date
Nov 4, 2026
Broker
J.P. Morgan Securities LLC
Acquired
Aug 13, 2024 · Inherited
Remarks
  1. The shares in this filing are to be sold by Stephanie Pitofsky.

More REGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.